|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$50,344
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Alliance NCORP Research Base
|
5UG1CA189823-05
|
$7,362,635
|
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
Kaiser Permanente NCI National Community Oncology Research Program NCORP
|
5UG1CA189821-05
|
$3,178,650
|
|
SUGA, JENNIFER
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-05
|
$3,106,081
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Heartland Cancer Research NCORP
|
5UG1CA189830-05
|
$2,990,806
|
|
FALLER, BRYAN
|
DECATUR MEMORIAL HOSPITAL
|
|
Cancer Research Consortium of West Michigan (CRCWM)
|
5UG1CA189860-05
|
$2,751,806
|
|
YOST, KATHLEEN
|
SPECTRUM HEALTH HOSPITALS
|
|
The CSBC Research Center for Cancer Systems Immunology at MSKCC
|
5U54CA209975-03
|
$2,409,446
|
|
LESLIE, CHRISTINA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
SPORE in Prostate Cancer
|
5P50CA180995-04
|
$2,289,160
|
|
CATALONA, WILLIAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Centers for Cancer Systems Therapeutics (CaST)
|
5U54CA209997-03
|
$2,090,840
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Center on the Physics of Cancer Metabolism
|
5U54CA210184-03
|
$2,021,161
|
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
|
5U54CA199075-04
|
$1,901,218
|
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Center for Immunotherapeutic Transport Oncophysics
|
5U54CA210181-03
|
$1,865,321
|
|
FERRARI, MAURO
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
Comparative Modeling to Inform Cervical Cancer Control Policies
|
5U01CA199334-04
|
$1,222,591
|
|
KIM, JANE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Nevada Cancer Research Foundation-NCI Community Oncology Research Program
|
5UG1CA189829-05
|
$1,142,055
|
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Mechanisms of regulation by RNA in acute myeloid leukemia
|
5R35CA197697-04
|
$1,042,185
|
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Medical University of South Carolina NCORP Minority/Underserved Community Site
|
5UG1CA189848-05
|
$1,009,670
|
|
HUGHES-HALBERT, CHANITA
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer.
|
5R44CA199826-03
|
$999,657
|
|
LI, YAJUAN
|
MOLECULAR THERANOSTICS, LLC
|
|
Minority-Based Community Oncology Research Program
|
5UG1CA189859-05
|
$972,757
|
|
SPARANO, JOSEPH
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
Carle Cancer Center NCI Community Oncology Research Progran (NCORP)
|
5UG1CA189861-05
|
$965,307
|
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
Sanford Community Cancer Program of the North Central Plains
|
5UG1CA189825-05
|
$940,075
|
|
STEEN, PRESTON
|
SANFORD RESEARCH/USD
|
|
Defining Drivers of HPV-associated Carcinogenesis
|
5R35CA210807-02
|
$918,000
|
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Harnessing the power of exosomes for non-coding RNA delivery
|
5R35CA209904-02
|
$905,873
|
|
SOOD, ANIL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Therapeutic Targeting of Malignant Glioma Stem Cells
|
5R35CA197725-05
|
$902,878
|
|
LESNIAK, MACIEJ
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Molecular strategies for early detection and targeting of cancer
|
5R35CA197699-04
|
$898,918
|
|
REYA, TANNISHTHA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
The Florida Pediatric NCORP
|
5UG1CA189973-05
|
$841,020
|
|
SALMAN, EMAD
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
Evaluation of Carcinogenic Risks to Humans
|
5U01CA033193-37
|
$821,807
|
|
STRAIF, KURT
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Immunoprevention and immunosurveillance of human non-viral cancers
|
5R35CA210039-03
|
$819,666
|
|
FINN, OLIVERA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Chile Gallbladder Cancer Study
|
ZIA CP010218 - 10540
|
$819,329
|
$819,329
|
Koshiol, Jill
|
DCEG (NCI)
|
|
South Texas Pediatric NCI Community Oncology Research Program (NCORP)
|
5UG1CA189855-05
|
$803,567
|
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Dayton Clinical Oncology Program
|
5UG1CA189957-05
|
$783,697
|
|
GROSS, HOWARD
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
Essentia Health Community Cancer Research Program NCORP
|
5UG1CA189812-05
|
$780,216
|
|
FRIDAY, BRET
|
ESSENTIA INSTITUTE OF RURAL HEALTH
|
|
Scalable Clinical Decision Support for Individualized Cancer Risk Management
|
5U24CA204800-02
|
$752,888
|
|
DEL FIOL, GUILHERME
|
UNIVERSITY OF UTAH
|
|
Somatic Cell Cycle Regulation by Phosphorylation
|
5R01CA080100-20
|
$724,488
|
|
HUNTER, TONY
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
Research at the interface of optical and ionizing radiation for innovative cancer imaging and therapy
|
5R35CA197608-04
|
$712,263
|
|
CHERRY, SIMON
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Precision Medicine Approach to Prostate Cancer Active Surveillance
|
5R01CA184712-05
|
$695,027
|
|
MOSQUERA, JUAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Nemours NCI Community Oncology Research Program (NCORP)
|
5UG1CA189958-05
|
$666,396
|
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Functional Characterization of Glioma GWAS Variants
|
5R01CA207972-03
|
$649,042
|
|
LAI, ROSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
ECM geometrical and mechanical properties modulate RTK signaling
|
5U01CA202241-04
|
$639,231
|
|
GROVES, JAY
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis
|
5U01CA217078-02
|
$597,821
|
|
BISSONNETTE, BRUCE
|
UNIVERSITY OF CHICAGO
|
|
Novel therapeutic approaches for enhancing anti-tumor immunity in SCLC
|
5U01CA213273-02
|
$596,039
|
|
HEYMACH, JOHN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Kansas City Clinical Oncology Program
|
5UG1CA189853-05
|
$579,996
|
|
GAUR, RAKESH
|
NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM
|
|
Microfluidic Device to Profile Chemosensitivity in Glioma Slice Cultures
|
5R01CA181445-05
|
$532,112
|
|
FOLCH, ALBERT
|
UNIVERSITY OF WASHINGTON
|
|
Training in Molecular& Genetic Epidemiology of Cancer
|
5R25CA112355-14
|
$525,610
|
|
WITTE, JOHN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-03
|
$518,165
|
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
UW Radiological Sciences Training Program
|
5T32CA009206-40
|
$499,580
|
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Therapeutic efficacy of the CRL inhibitor MLN4924 in NF2 mutant mesothelioma
|
5R01CA191222-03
|
$495,996
|
|
GIANCOTTI, FILIPPO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Molecular Risk Stratification for Colonoscopic Surveillance
|
5U01CA182367-04
|
$489,685
|
|
CHAN, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Gallbladder for this search: $956,261
|